Literature DB >> 7081123

The effects of antibiotics in the weanling pig diet on growth and the excretion of volatile phenolic and aromatic bacterial metabolites.

M T Yokoyama, C Tabori, E R Miller, M G Hogberg.   

Abstract

The purpose of this study was to investigate the effects of dietary antibiotic supplementation on the fecal urinary excretion of volatile phenolic and aromatic bacterial metabolites by the weanling pig, and to determine if a relationship exists between an exposure to these metabolites and growth performance. Wealing pigs were fed a basal diet, supplemented with either 110 ppm chlortetracycline, 110 ppm sulfamethazine and 55 ppm penicillin, 40 ppm lincomycin sulfate, or no antibiotics, for 30 days. Pigs on the chlortetracycline-sulfamethazine-penicillin diet on the average tended to grow at a faster rate, attained a higher percentage weight gain, and weighed slightly more than pigs on either the lincomycin sulfate or no antibiotic diets. Under all treatments, p-cresol was the predominant metabolite of the volatile phenolic and aromatic metabolites detected in feces and urine, with the urine accounting for 88% of its total daily excretion. Pigs on the chlortetracycline-sulfamethazine-penicillin diet excreted less urinary p-cresol than pigs on either the lincomycin sulfate or no antibiotic diets. Total p-cresol excretion expressed on the metabolic body size, resulted in significant treatment differences. Regression analysis of percentage body weight gain on urinary p-cresol excretion gave a negative correlation coefficient (r = -0.73). The results suggest that intestinal p-cresol production may be responsible for depressing the growth of the weanling pig.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7081123     DOI: 10.1093/ajcn/35.6.1417

Source DB:  PubMed          Journal:  Am J Clin Nutr        ISSN: 0002-9165            Impact factor:   7.045


  8 in total

1.  Neonatal environment exerts a sustained influence on the development of the intestinal microbiota and metabolic phenotype.

Authors:  Claire A Merrifield; Marie C Lewis; Bernard Berger; Olivier Cloarec; Silke S Heinzmann; Florence Charton; Lutz Krause; Nadine S Levin; Swantje Duncker; Annick Mercenier; Elaine Holmes; Mick Bailey; Jeremy K Nicholson
Journal:  ISME J       Date:  2015-06-12       Impact factor: 10.302

2.  Impact of narasin on manure composition, microbial ecology, and gas emissions from finishing pigs fed either a corn-soybean meal or a corn-soybean meal-dried distillers grains with solubles diets.

Authors:  Brian J Kerr; Steven L Trabue; Mark B van Weelden; Daniel S Andersen; Laura M Pepple
Journal:  J Anim Sci       Date:  2018-04-14       Impact factor: 3.159

Review 3.  Fate of undigested proteins in the pig large intestine: What impact on the colon epithelium?

Authors:  François Blachier; Mireille Andriamihaja; Xiang-Feng Kong
Journal:  Anim Nutr       Date:  2021-09-17

Review 4.  Gut microbiome in chronic kidney disease: challenges and opportunities.

Authors:  Anitha Nallu; Shailendra Sharma; Ali Ramezani; Jagadeesan Muralidharan; Dominic Raj
Journal:  Transl Res       Date:  2016-04-30       Impact factor: 7.012

5.  Prospective study of Clostridium difficile colonization and paracresol detection in the stools of babies on a special care unit.

Authors:  T J Phua; T R Rogers; A P Pallett
Journal:  J Hyg (Lond)       Date:  1984-08

6.  Isolation from swine feces of a bacterium which decarboxylates p-hydroxyphenylacetic acid to 4-methylphenol (p-cresol).

Authors:  L A Ward; K A Johnson; I M Robinson; M T Yokoyama
Journal:  Appl Environ Microbiol       Date:  1987-01       Impact factor: 4.792

Review 7.  Contributory Role of Gut Microbiota and Their Metabolites Toward Cardiovascular Complications in Chronic Kidney Disease.

Authors:  Daniel Y Li; W H Wilson Tang
Journal:  Semin Nephrol       Date:  2018-03       Impact factor: 5.299

8.  The intestine and the kidneys: a bad marriage can be hazardous.

Authors:  Raymond Vanholder; Griet Glorieux
Journal:  Clin Kidney J       Date:  2015-02-10
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.